DK1345959T3 - Membranscaffoldproteiner - Google Patents

Membranscaffoldproteiner

Info

Publication number
DK1345959T3
DK1345959T3 DK01995157.3T DK01995157T DK1345959T3 DK 1345959 T3 DK1345959 T3 DK 1345959T3 DK 01995157 T DK01995157 T DK 01995157T DK 1345959 T3 DK1345959 T3 DK 1345959T3
Authority
DK
Denmark
Prior art keywords
proteins
membrane
hydrophobic
bilayer
msp
Prior art date
Application number
DK01995157.3T
Other languages
English (en)
Inventor
Stephen G Sligar
Timothy H Bayburt
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of DK1345959T3 publication Critical patent/DK1345959T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK01995157.3T 2000-11-20 2001-11-20 Membranscaffoldproteiner DK1345959T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25223300P 2000-11-20 2000-11-20
PCT/US2001/043451 WO2002040501A2 (en) 2000-11-20 2001-11-20 Membrane scaffold proteins

Publications (1)

Publication Number Publication Date
DK1345959T3 true DK1345959T3 (da) 2011-09-05

Family

ID=22955155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01995157.3T DK1345959T3 (da) 2000-11-20 2001-11-20 Membranscaffoldproteiner

Country Status (10)

Country Link
US (4) US7048949B2 (da)
EP (1) EP1345959B1 (da)
JP (3) JP4303468B2 (da)
CN (1) CN1474831A (da)
AT (1) ATE510847T1 (da)
AU (2) AU2002225670B2 (da)
BR (1) BR0115475A (da)
CA (1) CA2429473C (da)
DK (1) DK1345959T3 (da)
WO (1) WO2002040501A2 (da)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949244B1 (en) 1995-12-20 2005-09-27 The Board Of Trustees Of The University Of Kentucky Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
DK1345959T3 (da) * 2000-11-20 2011-09-05 Univ Illinois Membranscaffoldproteiner
US7622437B2 (en) 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
EP2314285B2 (en) 2003-02-14 2019-09-18 Children's Hospital & Research Center at Oakland Lipophilic drug delivery vehicle and methods of use thereof
US7219018B2 (en) * 2003-09-11 2007-05-15 Franco Vitaliano Quantum information processing elements and quantum information processing platforms using such elements
US7219017B2 (en) 2003-09-11 2007-05-15 Franco Vitaliano Quantum information processing elements and quantum information processing platforms using such elements
US7216038B2 (en) 2003-09-11 2007-05-08 Franco Vitaliano Quantum information processing elements and quantum information processing platforms using such elements
US7393924B2 (en) * 2004-01-06 2008-07-01 Franco Vitaliano Smart bio-nanoparticle elements
ITRM20040357A1 (it) * 2004-07-16 2004-10-16 Paolo Abrescia Metodo per identificare agenti modulanti del metabolismo di molecole steroidee.
EP1771470B1 (en) * 2004-07-23 2013-06-26 Acceleron Pharma Inc. Actrii receptor polypeptides, methods and compositions
EP1812032A4 (en) * 2004-10-27 2009-09-02 Univ Illinois TISSUE FACTOR COMPOSITION AND RELATED METHODS
US20080248565A1 (en) * 2007-03-01 2008-10-09 Invitrogen Corporation Isolated phospholipid-protein particles
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
WO2007038755A1 (en) * 2005-09-27 2007-04-05 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include apolipoproteins and phospholipid-apolipoprotein particles
KR20190006086A (ko) 2005-11-23 2019-01-16 악셀레론 파마 인코포레이티드 액티빈-ａｃｔｒⅱａ 길항제 및 골 성장을 촉진하기 위한 이들의 용도
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
EP2111229B1 (en) 2007-02-01 2013-04-10 Acceleron Pharma, Inc. Pharmaceutical compositions comprising Activin-ActRIIA antagonists for use in preventing or treating breast cancer metastasis or breast cancer related bone loss
TWI782836B (zh) 2007-02-02 2022-11-01 美商艾瑟勒朗法瑪公司 衍生自ActRIIB的變體與其用途
ES2756725T3 (es) 2007-02-09 2020-04-27 Acceleron Pharma Inc Composiciones farmacéuticas que comprenden antagonistas de Activina-ActRIIA
US20110059549A1 (en) 2007-05-09 2011-03-10 Coleman Matthew A Methods and systems for producing nanolipoprotein particles
EP3243524A1 (en) 2007-09-18 2017-11-15 Acceleron Pharma Inc. Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
US9688718B2 (en) 2008-01-11 2017-06-27 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising hydrogenases and related products, methods and systems
WO2009097587A2 (en) * 2008-01-30 2009-08-06 The Rockefeller University Nanoscale bound bilayers, methods of use and production
CA2722183C (en) 2008-04-25 2018-09-18 Northwestern University Nanostructures suitable for sequestering cholesterol and other molecules
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
WO2009143280A2 (en) * 2008-05-22 2009-11-26 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
WO2009158678A1 (en) 2008-06-27 2009-12-30 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use therefor
SMT202300222T1 (it) 2008-08-14 2023-09-06 Acceleron Pharma Inc Trappole di gdf
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
KR100991486B1 (ko) 2008-10-08 2010-11-04 성균관대학교산학협력단 아미노산 태그가 신장된 ａｐｏＡ－Ｉ 단백질 및 인지질을 이용한 막 단백질의 고체 표면 고정화 방법
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
US11235062B2 (en) * 2009-03-06 2022-02-01 Metaqor Llc Dynamic bio-nanoparticle elements
US11096901B2 (en) 2009-03-06 2021-08-24 Metaqor Llc Dynamic bio-nanoparticle platforms
BRPI1010587A2 (pt) 2009-06-08 2019-04-09 Acceleron Pharma Inc. métodos para aumentar adipócitos termogênicos
EP2440577A4 (en) 2009-06-12 2013-01-23 Acceleron Pharma Inc SHORTEN ACTRIIB FC FUSION PROTEINS
JP5481746B2 (ja) * 2009-09-28 2014-04-23 公益財団法人東洋食品研究所 フロクマリン類の含有量を低減したイチジクの製造方法
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
US10525152B2 (en) 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
JP6267425B2 (ja) 2009-11-17 2018-01-24 アクセルロン ファーマ， インコーポレイテッド 筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用
US20120028820A1 (en) 2009-12-29 2012-02-02 Nanosense Inc. Hybrid sensor array
WO2011091065A2 (en) 2010-01-19 2011-07-28 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
US8865877B2 (en) * 2010-03-19 2014-10-21 Northwestern University Compositions and methods for solubilizing membrane proteins without the use of detergent
CN103298832A (zh) 2010-11-08 2013-09-11 阿塞勒隆制药公司 Actriia结合剂及其用途
EP2673296B1 (en) 2011-02-07 2018-10-24 Cerenis Therapeutics Holding SA Lipoprotein complexes and manufacturing and uses thereof
US8715987B2 (en) * 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
GB201110272D0 (en) 2011-06-17 2011-08-03 Isis Innovation Metod of detection by mass spectrometry
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
AU2013262709A1 (en) 2012-05-16 2015-01-22 Rana Therapeutics, Inc. Compositions and methods for modulating MECP2 expression
BR112014028634A2 (pt) 2012-05-16 2017-06-27 Rana Therapeutics Inc composições e métodos para modulação da expressão de utrn
US10837014B2 (en) 2012-05-16 2020-11-17 Translate Bio Ma, Inc. Compositions and methods for modulating SMN gene family expression
EA201492119A1 (ru) * 2012-05-16 2015-05-29 Рана Терапьютикс, Инк. Композиции и способы для модулирования экспрессии apoa1 и abca1
CA2873769A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics Inc. Compositions and methods for modulating hemoglobin gene family expression
CA2873766A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics Inc. Compositions and methods for modulating atp2a2 expression
JP2015523854A (ja) 2012-05-16 2015-08-20 ラナ セラピューティクス インコーポレイテッド Ｓｍｎ遺伝子ファミリー発現を調節するための組成物及び方法
NZ707477A (en) 2012-11-02 2019-09-27 Celgene Corp Activin-actrii antagonists and uses for treating bone and other disorders
EP2745834B1 (en) 2012-12-18 2016-09-28 Jens Frauenfeld Salipro particles
LT3043814T (lt) 2013-09-13 2021-02-25 Salipro Biotech AB Antigenas ir jo gamybos būdas
WO2015066080A2 (en) * 2013-10-28 2015-05-07 The Regents Of The University Of California Lipid co-factor essential for cell density signaling
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
WO2015192111A1 (en) 2014-06-13 2015-12-17 Acceleron Pharma, Inc. Methods and compositions for treating ulcers
US10519499B2 (en) * 2014-07-31 2019-12-31 Illumina, Inc. Hybrid nanopore sensors
US10961286B2 (en) * 2014-08-15 2021-03-30 Cornell University Nucleic acids, vectors, host cells, and methods for recombinantly producing water-soluble membrane proteins
WO2016028940A1 (en) 2014-08-19 2016-02-25 Northwestern University Protein/oligonucleotide core-shell nanoparticle therapeutics
WO2016049061A1 (en) 2014-09-22 2016-03-31 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems
CA2963931A1 (en) 2014-10-06 2016-04-14 Exicure, Inc. Anti-tnf compounds
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
JP2018501307A (ja) 2014-12-03 2018-01-18 セルジーン コーポレイション アクチビン−ＡｃｔＲＩＩアンタゴニスト及び貧血を治療するための使用
US10078092B2 (en) 2015-03-18 2018-09-18 Northwestern University Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
EP3297665A1 (en) 2015-05-16 2018-03-28 Batavia Biosciences Inc. Thermostable vaccines based on ether lipids and native viral envelope proteins
US12226529B2 (en) 2015-08-25 2025-02-18 Lawrence Livermore National Security, Llc Stable nanolipoprotein particles and related compositions methods and systems
WO2017044899A1 (en) 2015-09-11 2017-03-16 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
CN108779181A (zh) 2015-10-16 2018-11-09 国立输血研究院 生产红细胞蛋白质的方法
EP3368089B1 (en) 2015-10-26 2025-11-05 Translate Bio Ma, Inc. Nanoparticle formulations for delivery of nucleic acid complexes
CA3030855A1 (en) * 2016-07-18 2018-01-25 President And Fellows Of Harvard College Methods and compositions relating to covalently circularized nanodiscs
EP3284460A1 (en) 2016-08-19 2018-02-21 Salipro Biotech AG Saposin lipoprotein particles and libraries from crude membranes
WO2018204495A1 (en) 2017-05-02 2018-11-08 Synthetic Genomics, Inc. Nanolipoprotein particles and related compositions methods and systems for loading rna
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems
KR101994279B1 (ko) * 2017-11-03 2019-06-28 서울대학교산학협력단 후각 수용체 단백질을 포함하는 나노디스크의 제조방법과 이에 의하여 제조된 후각 수용체 단백질을 포함하는 나노디스크
WO2019200240A1 (en) 2018-04-13 2019-10-17 Board Of Regents, The University Of Texas System Transmembrane stem cell factor (tm-scf) lipid nanocarriers and methods of use thereof
WO2020154726A1 (en) * 2019-01-25 2020-07-30 Arizona Board Of Regents On Behalf Of The University Of Arizona Optical cavity surface bioconjugation using lipid membranes for label free, ultrasensitive detection of biomolecules
EP3725304A1 (en) 2019-04-15 2020-10-21 Salipro Biotech AB Production of salipro particles
CN110305205A (zh) * 2019-07-11 2019-10-08 江西晶美瑞生物医药有限公司 一种用于生产膜蛋白抗原的纳米圆盘的制备方法
US20220372496A1 (en) * 2019-09-24 2022-11-24 MVRIX Co., Ltd. Nano-perforator having improved anti-viral activity
JP7676380B2 (ja) 2019-10-30 2025-05-14 エフ． ホフマン－ラ ロシュ アーゲー 生物学的ナノポアのアセンブリのための方法及び組成物
US12596108B2 (en) * 2020-02-06 2026-04-07 Arizona Board Of Regents On Behalf Of The University Of Arizona Automated lipid exchange-mass spectrometry systems and methods
AU2021325965A1 (en) * 2020-08-14 2023-03-16 Mayo Foundation For Medical Education And Research Methods and materials for tissue ablation
TW202242114A (zh) 2020-12-23 2022-11-01 美商再生元醫藥公司 用於獲得結合至跨膜蛋白之抗體以及抗體生成細胞的方法
KR102539699B1 (ko) * 2021-04-19 2023-06-12 리셉텍 주식회사 Gpcr이 포함된 나노디스크가 장착된 항체 스크리닝 키트 및 이를 이용한 항체 의약품 스크리닝 방법
WO2023146356A1 (ko) * 2022-01-28 2023-08-03 성균관대학교산학협력단 막구조화 단백질이 결합된 항체를 포함하는 항체 결합 지질나노입자
JP2026511769A (ja) 2023-03-30 2026-04-14 エフ． ホフマン－ラ ロシュ アーゲー 標的分子脂質二重層の相互作用の調節
WO2025137409A1 (en) * 2023-12-21 2025-06-26 University Of Florida Research Foundation, Incorporated Supercharged lipid nanodiscs and methods of use
WO2025257777A1 (en) * 2024-06-12 2025-12-18 Janssen Biotech, Inc. Materials and methods for improved three-dimensional immunity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260209A (en) 1990-05-23 1993-11-09 University Of Iowa Research Foundation Nucleic acids encoding dystrophin-associated proteins
US5652339A (en) 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JP3062912B2 (ja) * 1994-04-26 2000-07-12 株式会社小糸製作所 車輌用灯具
US5903269A (en) * 1995-10-10 1999-05-11 Anysoft Ltd. Apparatus for and method of acquiring processing and routing data contained in a GUI window
US5889518A (en) * 1995-10-10 1999-03-30 Anysoft Ltd. Apparatus for and method of acquiring, processing and routing data contained in a GUI window
US6222542B1 (en) * 1995-10-10 2001-04-24 Anysoft, Ltd Apparatus for and method of acquiring, processing and routing data contained in a GUI window
US6172262B1 (en) * 1999-01-27 2001-01-09 Wisconsin Alumni Research Foundation Amphiphilic agents for membrane protein solubilization
US7083954B2 (en) * 1999-02-11 2006-08-01 Renessen Llc Method of producing fermentation-based products from corn
SE9902056D0 (sv) 1999-06-03 1999-06-03 Active Biotech Ab An integrin heterodimer and an alpha subunit thereof
AU6267000A (en) 1999-06-30 2001-01-22 Evotec Oai Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US7083958B2 (en) 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US7592008B2 (en) 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
DK1345959T3 (da) 2000-11-20 2011-09-05 Univ Illinois Membranscaffoldproteiner

Also Published As

Publication number Publication date
US20060057662A1 (en) 2006-03-16
AU2002225670B2 (en) 2006-05-11
CA2429473A1 (en) 2002-05-23
CA2429473C (en) 2011-02-15
EP1345959A4 (en) 2005-01-05
WO2002040501A3 (en) 2002-09-26
EP1345959A2 (en) 2003-09-24
EP1345959B1 (en) 2011-05-25
JP2004513653A (ja) 2004-05-13
US7662410B2 (en) 2010-02-16
JP4303468B2 (ja) 2009-07-29
BR0115475A (pt) 2004-02-10
US20060211092A1 (en) 2006-09-21
WO2002040501A2 (en) 2002-05-23
AU2567002A (en) 2002-05-27
US7048949B2 (en) 2006-05-23
JP2010138177A (ja) 2010-06-24
US20060211093A1 (en) 2006-09-21
CN1474831A (zh) 2004-02-11
US7575763B2 (en) 2009-08-18
JP4467610B2 (ja) 2010-05-26
US7691414B2 (en) 2010-04-06
ATE510847T1 (de) 2011-06-15
JP2008044958A (ja) 2008-02-28
US20050152984A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
ATE510847T1 (de) Membrangerüstproteine
EP2319495A3 (en) Membrane scaffold proteins
Varderidou-Minasian et al. Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities
Wickremasinghe et al. Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release
Dey et al. Multivalent flexible nanogels exhibit broad-spectrum antiviral activity by blocking virus entry
Zhang et al. Peptide amphiphile micelle vaccine size and charge influence the host antibody response
ES2639464T3 (es) Compuestos útiles para el tratamiento y/o cuidado de la piel y sus composiciones cosméticas o farmacéuticas
Steffan et al. Phagocytosis, an unrecognized property of murine endothelial liver cells
JP5409009B2 (ja) 組織工学の足場としての三次元再構成細胞外マトリクス
LoPresti et al. Controlling polymersome surface topology at the nanoscale by membrane confined polymer/polymer phase separation
Pértile et al. Bacterial cellulose modified using recombinant proteins to improve neuronal and mesenchymal cell adhesion
Toita et al. Development of human hepatocellular carcinoma cell-targeted protein cages
Gustafson et al. Synthesis and characterization of a matrix-metalloproteinase responsive silk–elastinlike protein polymer
Julier et al. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine
JP2008511662A (ja) 損傷組織の修復を促進するためのＷｎｔタンパク質を含む馴化培地
WO2001082958A3 (en) Methods of producing membrane vesicles
CN102083962A (zh) 生物体内功能性细胞的高效采集方法
WO2001068811A3 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
US20100168401A1 (en) Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes
JPWO2007132790A1 (ja) 細菌菌体成分を含む脂質膜を有するリポソーム
Kaufmann et al. The two-receptor system PAR-1/PAR-4 mediates α-thrombin-induced [Ca2+] i mobilization in human astrocytoma cells
WO2003059436A3 (en) Compositions and methods for promoting myocardial and peripheral angiogenesis
Doménech et al. Surface planar bilayers of phospholipids used in protein membrane reconstitution: an atomic force microscopy study
ES2989467T3 (es) Hidrogel para la respuesta inmune diseñada a péptidos con D-quiralidad
Liu et al. Influence of designer self‐assembling nanofiber scaffolds containing anti‐cancer peptide motif on hepatoma carcinoma cells